Search results for: Innovation Policy Prize

The Impact of New Medicines in the NHS: 70 Years of Innovation

14 August 2018

…new medicines. Seven themes arose from the interviews relating to i) the value of innovation, ii) complementarity and spillovers, iii) substitution, iv) policy, v) evidence, vi) understanding, and vii) collaboration….

Economic Aspects of the Development of New Medicines

1 January 1981

…success of pharmaceutical innovation. On the one hand there has been the spirit of enterprise in the pharmaceutical industry, characterised by competition, innovation, flexibility and a willingness to invest huge…

Evaluating Medical Innovation: The Societal View

8 April 2010

…mandatory guidelines for evaluating medical innovation now encourage or require this narrower, budget-based payer perspective.  As a result, they argue, decisions often are suboptimal, for both health care and economies…

Activity Based Funding for Hospitals: English Policy, International Experience

1 October 2004

…research to help the policy achieve its objectives. The English Department of Health’s key policy objectives for ‘payment by results’ are set out by Bob Dredge in the first chapter…

Policy, Organisation and Incentives in Health Systems

Policy, Organisation and Incentives in Health Systems Development of effective health system policy requires an understanding of organisational structures, funding streams, and incentive mechanisms that shape how healthcare interventions and…

R&D for new drugs to tackle AMR is a high-return investment for all EU member states

19 July 2024

…also predict high returns from this policy, with benefit-cost ratios in the EU ranging from 1.3:1 to 4.6:1 over 10 years, and from 6.1:1 to 21:1 over 30 years. Previously,…

The CBO Doesn’t Understand Investors

13 September 2021

…innovation (i.e., the relationship between a reduction in revenue and outputs of innovation) to expected revenues based on estimates from the academic literature at an aggregate industry level. Our later…

Paul Oyalo

12 August 2024

Paul Oyalo joined the OHE in August 2024 as Graduate Economist. Before joining us, Paul had previously worked on various research projects focusing on improving patient access to cancer therapies…

OHE Lunchtime Seminar: Management in the NHS

4 September 2017, 11:00pm

…and co-authors Martin Gaynor and Rodrigo Moreno-Serra were awarded the American Economic Association Prize for the best paper published in the American Economic Journal: Economic Policy in 2012-15. https://www.aeaweb.org/about-aea/honors-awards/aej-best-papers. In…